Department of Immunology, Mayo Clinic, Scottsdale, AZ, USA.
Laboratory of Molecular Immunology, Immunology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Trends Immunol. 2024 Nov;45(11):892-902. doi: 10.1016/j.it.2024.09.009. Epub 2024 Oct 10.
The development of mammalian adaptive (i.e., B and T cell-mediated) immune responses is tightly controlled at transcriptional, epigenetic, and metabolic levels. Signals derived from the extracellular milieu are crucial regulators of adaptive immunity. Beyond the traditionally studied cytokines and chemokines, many other extracellular metabolites can bind to specialized receptors and regulate T and B cell immune responses. These molecules often accumulate extracellularly through active export by plasma membrane transporters. For example, mammalian immune and non-immune cells express pannexin (PANX)1-3 channels on the plasma membrane, which release many distinct small molecules, notably intracellular ATP. Here, we review novel findings defining PANXs as crucial regulators of T and B cell immune responses in disease contexts such as cancer or viral infections.
哺乳动物适应性(即 B 和 T 细胞介导)免疫反应的发展在转录、表观遗传和代谢水平上受到严格控制。来自细胞外环境的信号是适应性免疫的关键调节剂。除了传统上研究的细胞因子和趋化因子外,许多其他细胞外代谢物可以与特异性受体结合,调节 T 和 B 细胞免疫反应。这些分子通常通过质膜转运蛋白的主动外排而在细胞外积累。例如,哺乳动物免疫和非免疫细胞在质膜上表达连接蛋白 (PANX)1-3 通道,释放许多不同的小分子,特别是细胞内 ATP。在这里,我们回顾了新的发现,这些发现将 PANX 确定为癌症或病毒感染等疾病情况下 T 和 B 细胞免疫反应的重要调节剂。